Efficacy and safety of rituximab versus intravenous cyclophosphamide for systemic sclerosis-associated interstitial lung disease: a retrospective cohort study

Systemic Sclerosis

Gastroesophageal reflux disease is associated with a more severe interstitial lung disease in systemic sclerosis in the EUSTAR cohort

Rheumatology (Oxford)

Roth E, Bruni C, Petelytska L, Becker MO, Dobrota R, Jordan S, Mihai C, Muraru S, Carreira PE, De Vries-Bouwstra J, Braun-Moscovici Y, Liakouli V, Moroncini G, Bergmann C, Mouthon L, Denton CP, De Santis M, Cauli A, Adler S, Bernardino V, Truchetet ME, Vonk M, Del Galdo F, Hoffmann-Vold AM, Distler O, Elhai M, EUSTAR collaborators

doi: 10.1093/rheumatology/keaf016

Systemic Sclerosis

Tocilizumab and rituximab for systemic sclerosis interstitial lung disease: a real-world cohort analysis

Rheumatology (Oxford)

Goldman NR, Nihtyanova SI, Beesley CF, Wells AU, Denton CP, Renzoni EA, Mageed R, Ong VH

doi: 10.1093/rheumatology/keaf006

Systemic Sclerosis

Total lung capacity is predictive of disease severity and survival in systemic sclerosis: A longitudinal analysis in 2347 patients from the French National Cohort Study

J Autoimmun

Chaigne B, Bense A, Aubourg F, Agard C, Allanore Y, Berezne A, Pugnet G, Hachulla E, Cottin V, Hot A, Dunogue B, Kanagaratnam A, Palat S, Lescoat A, Berthier S, Chatelus E, Rivière S, Launay D, Truchetet ME, Dinh-Xuan AT, Mouthon L, French Systemic Sclerosis Network

doi: 10.1016/j.jaut.2025.103391

Systemic Sclerosis

Thermographic abnormalities associate with electrocardiogram/echocardiographic changes and mortality in systemic sclerosis: a retrospective cohort study

Rheumatology (Oxford)

Villar MJ, Di Donato S, Bozan MF, Manning J, Mandzuk M, Wragg E, Samaranayaka M, Murray A, Herrick AL, Dinsdale G, Hughes M

doi: 10.1093/rheumatology/keaf383

Rheumatoid Arthritis

Impact of systemic inflammation and disease activity on the incidence of interstitial lung disease in patients with rheumatoid arthritis - a nested case-control study within the German biologics register RABBIT

Arthritis Res Ther

Ramien R, Rudi T, Alten R, Krause A, Schneider M, Schaefer M, Strangfeld A, Meissner Y

doi: 10.1186/s13075-024-03449-9

Systemic Sclerosis

Evaluation of the mycophenolate mofetil-rituximab combination in systemic sclerosis: a French retrospective multicenter study (MycRiSSc)

J Autoimmun

Barde F, Chevalier K, Decker P, Merin M, Nicolas A, Lescoat A, Deroux A, Koether V, Chatelus E, Coustal C, Maria A, Michaud M, Pugnet G, Murarasu A, Riviere S, Charles P, de Moreuil C, Lodovichetti J, Maillet F, Renaud A, Granel B, Mouthon L, Chaigne B

doi: 10.1016/j.jaut.2025.103492

Systemic Lupus Erythematosus

Interstitial lung disease in systemic lupus erythematosus: a 30-year population study

Rheumatology (Oxford)

Ng DM, Keen HI, Preen DB, Inderjeeth CA, Nossent JC

doi: 10.1093/rheumatology/keaf597

Autoimmune Disease

Lung transplantation outcomes of patients with interstitial pneumonia with autoimmune features: a single center retrospective cohort study

Rheumatology (Oxford)

Yu A, Kim H, Levy RD, Wilson JM, Jalaledin DS, Choi J, Yee J, Poirier CD, Hoa SA, Landon-Cardinal O, Huang K

doi: 10.1093/rheumatology/keaf299

Rheumatoid Arthritis

The diagnostic utility of lung ultrasound in the assessment of interstitial lung disease associated with rheumatoid arthritis

Arthritis Res Ther

Zheng S, Zhou Z, Du G, Chen Q, Chen S, Lin J, Hu S, Zhang W, Zheng K, Zhuang J, Huang M, Ruaro B, Bruni C, Hoffmann-Vold AM, Matucci-Cerinic M, Furst DE, Wang Y

doi: 10.1186/s13075-025-03626-4

Related content

Gastroesophageal reflux disease is associated with a more severe interstitial lung disease in systemic sclerosis in the EUSTAR cohort

Tocilizumab and rituximab for systemic sclerosis interstitial lung disease: a real-world cohort analysis

Total lung capacity is predictive of disease severity and survival in systemic sclerosis: A longitudinal analysis in 2347 patients from the French National Cohort Study

Thermographic abnormalities associate with electrocardiogram/echocardiographic changes and mortality in systemic sclerosis: a retrospective cohort study

Impact of systemic inflammation and disease activity on the incidence of interstitial lung disease in patients with rheumatoid arthritis - a nested case-control study within the German biologics register RABBIT

Evaluation of the mycophenolate mofetil-rituximab combination in systemic sclerosis: a French retrospective multicenter study (MycRiSSc)

Interstitial lung disease in systemic lupus erythematosus: a 30-year population study

Lung transplantation outcomes of patients with interstitial pneumonia with autoimmune features: a single center retrospective cohort study

The diagnostic utility of lung ultrasound in the assessment of interstitial lung disease associated with rheumatoid arthritis